Article Text
Abstract
Young children with cancer are treated with interventions that can have a high risk of compromising their reproductive potential. ‘Fertility preservation’ for children who have not yet reached puberty involves surgically removing and cryopreserving reproductive tissue prior to treatment in the expectation that strategies for the use of this tissue will be developed in the future. Fertility preservation for prepubertal children is ethically complex because the techniques largely lack proven efficacy for this age group. There is professional difference of opinion about whether it is ethical to offer such ‘experimental’ procedures. The question addressed in this paper is: when, if ever, is it ethically justifiable to offer fertility preservation surgery to prepubertal children? We present the ethical concerns about prepubertal fertility preservation, drawing both on existing literature and our experience discussing this issue with clinicians in clinical ethics case consultations. We argue that offering the procedure is ethically justifiable in certain circumstances. For many children, the balance of benefits and burdens is such that the procedure is ethically permissible but not ethically required; when the procedure is medically safe, it is the parents’ decision to make, with appropriate information and guidance from the treating clinicians. We suggest that clinical ethics support processes are necessary to assist clinicians to engage with the ethical complexity of prepubertal fertility preservation and describe the framework that has been integrated into the pathway of care for patients and families attending the Royal Children’s Hospital in Melbourne, Australia.
- children
- clinical ethics
- cryobanking of sperm
- ova or embryos
- ethics committees/consultation
- paediatrics
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
Footnotes
Contributors All authors conceptualised the paper’s argument, drawing on their experience in clinical ethics case consultations together. RJM wrote the first draft, which was then substantially edited by LG, CMD and YJ.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Other content recommended for you
- Inconsistencies in fertility preservation for young people with cancer in the UK
- Fifteen-minute consultation: Fertility preservation in children with cancer
- Gender-specific aspects related to type of fertility preservation strategies and access to fertility care
- TurnerFertility trial: PROTOCOL for an observational cohort study to describe the efficacy of ovarian tissue cryopreservation for fertility preservation in females with Turner syndrome
- Preservation of fertility in children treated for cancer
- Fertility preservation in patients with BRCA mutations or Lynch syndrome
- Surviving cancer or future motherhood? Both are possible: an Ewing sarcoma case in an 8-year-old girl
- Why are women considering ovarian tissue cryopreservation to preserve reproductive and hormonal ovarian function? A qualitative study protocol
- Fertility considerations prior to conservative management of gynecologic cancers
- Preserving fertility: using cyclophosphamide and other cytotoxics in young people